Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
Recruiting · NCT02253251 · Registry updated 2025-01-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Skin and Connective Tissue Diseases, Urogenital Diseases, Urogenital Neoplasms, autoimmune disease, breast disorder, breast neoplasm, cancer, endocrine system disorder, endometriosis, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, immune system disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder, skin disorder | Recruiting | Not stated | 2025-01-23 | NCT02253251 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| MiraKind | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| MiraKind | Los Angeles | United States | 1 |